Use of Indipamide to reduce progression of disability in people with primary and secondary progressive multiple sclerosis (MS).

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 593b6f51bc5e2fc38b08237d7eb700979baf1f12
First added on: Aug 10, 2026